Peer-Review Record
Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on “Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57”
Diagnostics 2022, 12(8), 1837; https://doi.org/10.3390/diagnostics12081837
by
Maria-Luiza Luchian 1,*, Andreea Motoc 1, Stijn Lochy 1, Julien Magne 2,3, Dries Belsack 4, Johan De Mey 4, Bram Roosens 1, Karen Van den Bussche 1, Sven Boeckstaens 1, Hadischat Chameleva 5, Jolien Geers 1, Laura Houard 1, Tom De Potter 5, Sabine Allard 6
, Caroline Weytjens 1, Steven Droogmans 1 and Bernard Cosyns 1
, Caroline Weytjens 1, Steven Droogmans 1 and Bernard Cosyns 1Reviewer 1:
Anonymous
Reviewer 2:
Diagnostics 2022, 12(8), 1837; https://doi.org/10.3390/diagnostics12081837
Submission received: 12 July 2022
/
Revised: 26 July 2022
/
Accepted: 27 July 2022
/
Published: 29 July 2022
(This article belongs to the Section Medical Imaging and Theranostics)
Round 1
Reviewer 1 Report
Be more clear please in your argumentation
Author Response
please see the attachment.
Author Response File: 
Author Response.pdf
Reviewer 2 Report
This is a nice debat about the cardiovascular complications (and not only) of COVID-19 infection.
Please consider the following reference (https://pubmed.ncbi.nlm.nih.gov/35627438/) when talking about echocardiographic evaluation of COVID-19 related myocardial disfunction
Author Response
please see the attachment.
Author Response File: Author Response.pdf
